yep, there’s a considerable overhang at 2.5 to churn through if you assume the sophs will sell their placements to free carry options.The options pose a significant risk to share price appreciation imo.
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
